CAMBRIDGE, Mass.—Flagship Pioneering, a scientific innovation engine for transformative platforms and products, and Amazon Web Services (AWS) today announced a strategic collaboration to accelerate the development and scaling of breakthrough life sciences companies.
Within this collaboration, AWS will be the preferred cloud provider for Flagship, supporting its companies as they build and scale digitally native and AI-native platforms and products across human health, sustainability, and other critical scientific domains. Flagship's early-stage companies will receive comprehensive technical support to fully leverage AWS's cloud and AI services, AWS cloud credits, and go-to-market resources to reach AWS's network of customers. Flagship’s internal teams of scientists and engineers, including members of its Pioneering Intelligence Initiative, will also receive specialized support to enhance their company creation and scaling capabilities.
"AI is no longer a theoretical tool in the life sciences—it’s a catalyst that’s fundamentally accelerating how we understand nature and generate breakthroughs,” said Avak Kahvejian, President of Flagship Labs and General Partner, Flagship Pioneering. "This collaboration with AWS will enable Flagship Labs and our companies to access more technological capabilities to push scientific boundaries further and faster."
“Life science innovation increasingly depends on the ability to compute at scale, experiment rapidly, and move seamlessly from discovery to deployment,” said Jason Bennett, Vice President and Global Head of Startups at AWS. "Through this collaboration with Flagship Pioneering, we're providing reliable, secure, and scalable infrastructure and AI capabilities that enable startups rapid experimentation and scaling of breakthrough discoveries, ultimately helping to transform how we approach everything from drug discovery to climate change."
The collaboration follows successful collaborations between AWS and Flagship-founded companies, including Moderna and Lila Sciences.
About Flagship Pioneering
Flagship Pioneering invents and builds platform companies, each with the potential for multiple products that transform human health, sustainability and beyond. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, operating with $14 billion of assets under its direction as of its latest capital raise, announced in July 2024. The current Flagship ecosystem comprises more than 40 companies, including Foghorn Therapeutics, Generate Biomedicines, Inari, Indigo Agriculture, Lila Sciences, Moderna, Sana Biotechnology, Tessera Therapeutics and Valo Health.